Risk Factors of the Failure of Surfactant Treatment by Transient Intubation during Nasal Continuous Positive Airway Pressure in Preterm Infants

ABSTRACT

We sought to identify risk factors and neonatal outcomes associated with the failure of the INSURE method (intubation–surfactant–extubation) during nasal continuous positive airway pressure for preterm infants with respiratory distress syndrome. We used a retrospective analysis of the prenatal histories, clinical courses, and laboratory data of all inborn infants with gestational age 27 to 34 weeks and respiratory distress syndrome treated with INSURE method. Infants were categorized into two groups: INSURE failure group and INSURE success group. One hundred nine infants were eligible to the study. INSURE failure was registered in 35 infants (32.1%). After control for confounding variables, INSURE failure was significantly associated with arterial partial pressure of carbon dioxide (adjusted odds ratio [OR] = 1.82; 95% confidence interval [CI] = 1.76 to 90.56), mean arterial-to-alveolar oxygen tension ratio (adjusted OR = 1.13; 95% CI = 1.06 to 85.34) and severe radiological grade (adjusted OR = 1.31; 95% CI = 1.15 to 70.16). Positive predictive values of these variables were 70, 75, and 55%, respectively. Patent ductus arteriosus and mortality rates were significantly higher in INSURE failure group. Arterial partial pressure of carbon dioxide, arterial-to-alveolar oxygen tension ratio, and severe radiological grade are predictors of the failure of INSURE method in preterm infants with respiratory distress syndrome. However, a prospective randomized controlled trial is needed to determine whether or not infants at risk for INSURE failure are better off being treated with mechanical ventilation.

Preterm infant - surfactant - respiratory distress syndrome - nasal continuous positive airway pressure

REFERENCES

• 1 De Klerk A M, De Kkerk R K. Nasal continuous positive airway pressure and outcomes of preterm infants.  J Paediatr Child Health. 2001;  37 161-167
• 2 Gittermann M K, Fusch C, Gitterman A R, Regazzoni B M, Moessinger A C. Early nasal continuous positive airway pressure treatment reduces the need for intubation in very low weight infants.  Eur J Pediatr. 1997;  156 384-388
• 3 Polin R A, Sahni R. Newer experience with CPAP.  Semin Neonatol. 2002;  7 379-389
• 4 Verder H, Robertson B, Greisen G et al.. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group.  N Engl J Med. 1994;  331 1051-1055
• 5 Verder H, Albertsen P, Ebbesen F et al.. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation.  Pediatrics. 1999;  103 E24
• 6 Bohlin K, Gudmundsdottir T, Katz-Salamon M, Jonsson B, Blennow M. Implementation of surfactant treatment during continuous positive airway pressure.  J Perinatol. 2007;  27 422-427
• 7 Kero P O, Makinen E O. Comparison between clinical and radiological classification of infants with the respiratory distress syndrome (RDS).  Eur J Pediatr. 1979;  130 271-278
• 8 Papile L A, Burstein J, Burstein R, Keffler H. Incidence and evolution of the subependymal intraventricular haemorrhage: a study of infants weighing less than 1500 grams.  J Pediatr. 1978;  92 529-534
• 9 Bell M J, Ternberg J L, Feigin R D et al.. Neonatal necrotizing enterocolitis: therapeutic decisions based on clinical staging.  Ann Surg. 1978;  187 1-7
• 10 de Vries L S, Eken P, Dubowitz L M. The spectrum of leukomalacia using cranial ultrasound.  Behav Brain Res. 1992;  49 1-6
• 11 Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity.  Am J Perinatol. 2001;  18 1-9
• 12 The Committee for the Classification of Retinopathy of Prematurity . An international classification of retinopathy of prematurity . Arch Opthalmol. 1984;  102 1130-1134
• 13 The International Liaison Committee on Resuscitation (ILCOR) Consensus on Science with Treatment Recommendations for Pediatric and Neonatal Patients . neonatal resuscitation.  Pediatrics. 2006;  117 e978-e988
• 14 Merran A T. (IFDAS study group) . Early nasal continuous positive airway pressure with prophylactic surfactant for neonates at risk of RDS: the IFDAS multi-center randomized trial.  Pediatr Res. 2002;  51 379A
• 15 Morley C J, Davis P G, Doyle L W, Brion L P, Hascoet J M, Carlin J B. COIN Trial Investigators . Nasal CPAP or intubation at birth for very preterm infants.  N Engl J Med. 2008;  358 700-708
• 16 Andersen T, Holm H S, Kamper J. Surfactant treatment of newborn infants receiving continuous positive airway pressure treatment.  Ugeskr Laeger. 2006;  168 3723-3727
• 17 Reininger A, Khalak R, Kendig J W et al.. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial.  J Perinatol. 2005;  25 703-708
• 18 Dani C, Bertini G, Pezzati M, Cecchi A, Cavoglioli C, Rubaltelli F F. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants < 30 weeks' gestation.  Pediatrics. 2004;  113 e560-e563
• 19 Ammari A, Suri M, Milisavljevic V et al.. Variables associated with the early failure of nasal CPAP in very low birth weight infants.  J Pediatr. 2005;  147 341-347
• 20 Achour W, Abbassi M S, Cherif A, Jabnoun S, Khrouf N, Ben Hassen A. Nosocomial respiratory infection due to an imipenem-resistant Pseudomonas aeruginosa O:12 strain in a Tunis's neonatal intensive care unit.  Pathol Biol. 2006;  54 596-599